Current Medical Management of Secondary Hyperparathyroidism
- 1 August 2000
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 320 (2) , 100-106
- https://doi.org/10.1097/00000441-200008000-00007
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nocturnal hemodialysisJournal of the American Society of Nephrology, 1998
- Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failureAmerican Journal of Kidney Diseases, 1997
- Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriolKidney International, 1991
- Calcium and Phosphorus Fluxes During Hemodialysis With Low Calcium DialysateAmerican Journal of Kidney Diseases, 1991
- Intestinal absorption of magnesium from food and supplements.Journal of Clinical Investigation, 1991
- Calcium acetate, an effective phosphorus binder in patients with renal failureKidney International, 1989
- Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.Journal of Clinical Investigation, 1989
- SUBSTITUTION OF ALUMINIUM SALTS BY MAGNESIUM SALTS IN CONTROL OF DIALYSIS HYPERPHOSPHATAEMIAThe Lancet, 1986
- Comparison of Control of Serum Phosphate Levels during Continuous Ambulatory Peritoneal Dialysis and during HemodialysisPeritoneal Dialysis International, 1983
- The Effect of Aluminium Hydroxide on Calcium, Phosphorus and Aluminium Balances, the Serum Parathyroid Hormone Concentration and the Aluminium Content of Bone in Patients with Chronic Renal FailureClinical Science, 1972